Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.
about
Suppression of frequently recurring genital herpes: acyclovir v inosine pranobexLong-term suppression of severe recurrent genital herpes simplex infections with oral acyclovir: a dose-titration study.The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes.Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infectionGenital herpes: review of the epidemic and potential use of type-specific serologyO'Brien-Bell leaves office with his concerns about two-tier system growing. Interview by Terry MoranProgress in meeting today's demands in genital herpes: an overview of current management.New antiviral and antifungal drugs.Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.Patient satisfaction with care for genital herpes: insights from a global survey.Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.Genital herpes: antiviral therapy for symptom relief and prevention of transmission.Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs.Protection from lethal herpes simplex virus type 1 infection by vaccination with a UL41-deficient recombinant strain.Herpes simplex virus and human papillomavirus genital infections: new and investigational therapeutic options.Skin diseases of the vulva: Infectious diseases.2017 European guidelines for the management of genital herpes.Valaciclovir: development, clinical utility and potential.Antiviral chemotherapy in genital herpes simplex virus infections.Reconsidering our approaches to Otitis media.Quebec City set to host CMA's 122nd annual meeting.European guideline for the management of genital herpes, 2010.Introduction to Treating Obesity.A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection
P2860
Q33931987-EE5E9AEC-82C0-4F94-A2A9-1F187DE02EC4Q33932537-AE7BF6C5-EA36-490F-BC21-9EC0B526F1F5Q33934635-3FF131C7-6834-46CF-A62A-932C91FDE95DQ33937215-A10A5F2C-E1E7-447F-A33A-A1AEF5CE3B9EQ33975387-8F19D2B7-5E1C-40DE-BA0A-B9FAA94F7306Q34104198-6A59B03C-8789-4852-84A4-90E5C519F12BQ34918299-F3A8E352-3136-43C3-B2E3-3D770BD09E50Q35168469-FADDEAAA-45CC-432C-9696-E6CD15E9ECFBQ35328407-7F757024-C5A4-4B1A-A55F-E816DAC799C5Q35531277-47A7F417-81A7-43DC-8DB7-499392C5EA3CQ36170672-14A68D02-F697-4A99-B165-5A26DF71C68FQ36429709-2DF116CA-0ACD-4C09-A14B-586C88B39864Q36829250-701EBA46-E229-42B1-BA79-6C690CFEFAB2Q37460924-7DA83663-177A-4509-AA6B-5D4643807CF7Q37771396-E5B075C6-4B36-40A1-9D4C-63A924801AC3Q39233693-A79DF700-0CEC-4A72-843C-48E3FFB9139BQ40072392-41A35E75-052F-4581-9811-736301528DBCQ40904060-88B1AAA1-020A-4BF0-869E-F27FDF1FDE5FQ40938400-7BFB0967-D9DC-4D27-8715-D0331AB822F4Q45813462-86C55173-3DC9-467D-9653-0B70DCAEA94CQ49474624-F28C4927-2789-44F2-99D9-156D268141E4Q50525827-974EEAC8-548D-4801-BE00-D8CCE58B1554Q55552701-643F2DEB-78BC-435C-955D-0D18B4A830B2Q55982673-00D0745B-8BC3-4A84-A25F-B32F3603EEEC
P2860
Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Dosage and safety of long-term ...... for recurrent genital herpes.
@en
Dosage and safety of long-term ...... for recurrent genital herpes.
@nl
type
label
Dosage and safety of long-term ...... for recurrent genital herpes.
@en
Dosage and safety of long-term ...... for recurrent genital herpes.
@nl
prefLabel
Dosage and safety of long-term ...... for recurrent genital herpes.
@en
Dosage and safety of long-term ...... for recurrent genital herpes.
@nl
P2093
P1433
P1476
Dosage and safety of long-term ...... for recurrent genital herpes.
@en
P2093
P304
P356
10.1016/S0140-6736(88)91725-4
P407
P577
1988-04-01T00:00:00Z